Skip to main content

CORRECTION article

Front. Virol., 31 January 2023
Sec. Antivirals and Vaccines
Volume 3 - 2023 | https://doi.org/10.3389/fviro.2023.1130102

Corrigendum: The influenza hemagglutinin stem antibody CR9114: Evidence for a narrow evolutionary path towards universal protection

This article is a correction to:

  1. The influenza hemagglutinin stem antibody CR9114: Evidence for a narrow evolutionary path towards universal protection

    1. Read original article
Anna L. Beukenhorst,&#x;Anna L. Beukenhorst1,2†Jacopo Frallicciardi*&#x;Jacopo Frallicciardi1*†Clarissa M. KochClarissa M. Koch1Jaco M. KlapJaco M. Klap1Angela PhillipsAngela Phillips3Michael M. DesaiMichael M. Desai3Kanin WichapongKanin Wichapong4Gerry A. F. NicolaesGerry A. F. Nicolaes4Wouter KoudstaalWouter Koudstaal1Galit Alter,Galit Alter1,5Jaap Goudsmit,Jaap Goudsmit1,6
  • 1Leyden Laboratories B.V., Amsterdam, Netherlands
  • 2Department of Biostatistics, Harvard TH Chan School of Public Health, Boston, MA, United States
  • 3Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, MA, United States
  • 4Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, Netherlands
  • 5Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT), and Harvard, Cambridge, MA, United States
  • 6Departments of Epidemiology, Immunology and Infectious Diseases, Harvard TH Chan School of Public Health, Boston, MA, United States

A corrigendum on
The influenza hemagglutinin stem antibody CR9114: Evidence for a narrow evolutionary path towards universal protection

by Beukenhorst AL, Frallicciardi J, Koch CM, Klap JM, Phillips A, Desai MM, Wichapong K, Nicolaes GAF, Koudstaal W, Alter G and Goudsmit J (2022) 2:1049134. doi: 10.3389/fviro.2022.1049134

In the published article, there was an error in the Author List. The author Jaco M. Klap was erroneously excluded. The corrected Author List appears below.

Anna L. Beukenhorst, Jacopo Frallicciardi, Clarissa M. Koch, Jaco M. Klap, Angela Phillips, Michael M. Desai, Kanin Wichapong, Gerry A. F. Nicolaes, Wouter Koudstaal, Galit Alter and Jaap Goudsmit

In the published article, there was an error in the Author Contributions. The author Jaco M. Klap was erroneously excluded. The corrected Author Contributions appears below.

AB and JF contributed equally to the writing of this article. AB, JF, CK, JK and JG designed this article. WK, GA, CK, and JG contributed to the article and provided critical remarks. KW and GAFN performed the structural analysis, JK analyzed the in vitro neutralization data for the landscape. AP and MMD contributed to the parts regarding the evolutionary pathway of pan-influenza protection. All authors contributed to the article and approved the submitted version.

In the published article, there was an error in the Conflict of Interest Statement. The author Jaco M. Klap was erroneously excluded. The corrected Conflict of Interest Statement appears below.

AB, JF, CK, JK, WK, GA, and JG have disclosed that they are employees of Leyden Laboratories with stock options in this company.

The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

In the published article, there was an error in the Acknowledgements. The author Jaco M. Klap was erroneously included in the acknowledgements when he should have been added as an author. The corrected Acknowledgements appears below.

We thank Carolyn Boudreau for the useful discussions.

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: broadly neutralizing antibodies, influenza virus, pan-influenza protection, CR9114, correlate of protection, antiviral therapies, immunization, vaccination

Citation: Beukenhorst AL, Frallicciardi J, Koch CM, Klap JM, Phillips A, Desai MM, Wichapong K, Nicolaes GAF, Koudstaal W, Alter G and Goudsmit J (2023) Corrigendum: The influenza hemagglutinin stem antibody CR9114: Evidence for a narrow evolutionary path towards universal protection. Front. Virol. 3:1130102. doi: 10.3389/fviro.2023.1130102

Received: 22 December 2022; Accepted: 17 January 2023;
Published: 31 January 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Beukenhorst, Frallicciardi, Koch, Klap, Phillips, Desai, Wichapong, Nicolaes, Koudstaal, Alter and Goudsmit. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Jacopo Frallicciardi, jacopo.frallicciardi@leydenlabs.com

†These authors have contributed equally to this work and share first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.